These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39073053)

  • 1. Reply to the letter, "Residual shunt after patent foramen ovale closure: The devil is in the details!" regarding article "Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure".
    Nakayama R; Takaya Y; Akagi T; Takemoto R; Haruna M; Nakashima M; Miki T; Nakagawa K; Toh N; Nakamura K; Yuasa S
    Catheter Cardiovasc Interv; 2024 Jul; ():. PubMed ID: 39073053
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure.
    Nakayama R; Takaya Y; Akagi T; Takemoto R; Haruna M; Nakashima M; Miki T; Nakagawa K; Toh N; Nakamura K
    Cardiovasc Interv Ther; 2024 Apr; 39(2):200-206. PubMed ID: 38265606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
    van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
    Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk mitigation in divers with persistent (patent) foramen ovale.
    Wilmshurst P
    Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual shunt after patent foramen ovale closure: The devil is in the details!
    Beneki E; Dimitriadis K; Kalompatsou A; Tsioufis K; Aggeli C
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):751. PubMed ID: 38426632
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale.
    Rana BS; Shapiro LM; McCarthy KP; Ho SY
    Eur J Echocardiogr; 2010 Dec; 11(10):i19-25. PubMed ID: 21078835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice, resource utilization, and outcomes of device closure of patent foramen ovale in pediatrics.
    Menon SC; Grove A; McFadden M; Korgenski KE; Cowley CG
    Pediatr Neurol; 2014 Mar; 50(3):213-7. PubMed ID: 24433855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual Right-to-Left-Shunt Following Transcatheter Patent Foramen Ovale Closure: The Role of Antithrombotic Treatment.
    Katsianos E; Oikonomou E; Kalogeras K; Manousaki A; Kalantzis C; Pantelidis P; Vavuranakis MA; Aggeli K; Siasos G; Tsioufis C; Vavuranakis M
    Curr Pharm Des; 2022; 28(40):3305-3312. PubMed ID: 36306457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
    Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter closure for decompression sickness with a patent foramen ovale: A case report.
    Jiang F
    J Interv Med; 2021 Aug; 4(3):149-151. PubMed ID: 34805964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we there yet with patent foramen ovale closure for secondary prevention in cryptogenic stroke? A systematic review and meta-analysis of randomized trials.
    Agasthi P; Kolla KR; Yerasi C; Tullah S; Pulivarthi VS; Louka B; Arsanjani R; Yang EH; Mookadam F; Fortuin FD
    SAGE Open Med; 2019; 7():2050312119828261. PubMed ID: 30783525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo study of a reserved atrial septal puncture area patent foramen ovale occluder.
    Jiang H; Cao S; Wang R; Wang S; He Z; Xu X; Yang C; Liu X
    Cardiol Young; 2023 Sep; 33(9):1581-1586. PubMed ID: 36065734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention: Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography.
    Reibel I; Hauguel-Moreau M; Guedeney P; Hage G; Hammoudi N; Duthoit G; Zeitouni M; Lattuca B; Kernéis M; Collet JP; Silvain J; Montalescot G;
    Arch Cardiovasc Dis; 2023 Nov; 116(11):523-528. PubMed ID: 37838576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
    JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale.
    Berdat PA; Chatterjee T; Pfammatter JP; Windecker S; Meier B; Carrel T
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1034-9. PubMed ID: 11088023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.